Characterization of the genome and structural proteins of hepatitis C virus resolved from infected human liver

被引:54
作者
Nielsen, SU
Bassendine, MF
Burt, AD
Bevitt, DJ
Toms, GL
机构
[1] Med Sch Newcastle Upon Tyne, Sch Clin Med Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[2] Med Sch Newcastle Upon Tyne, Sch Clin & Lab Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
基金
英国惠康基金;
关键词
D O I
10.1099/vir.0.79967-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In the absence of satisfactory cell culture systems for hepatitis C virus (HCV), virtually all that is known about the proteins of the virus has been learned by the study of recombinant proteins. Characterization of virus proteins from patients with HCV has been retarded by the low virus titre in blood and limited availability of infected tissue. Here, the authors have identified a primary infection in a liver transplanted into an immunodeficient patient with chronic HCV. The patient required re-transplant and the infected liver, removed 6 weeks after the initial transplant, had a very high titre of HCV, 5 x 10(9) International Units (IU) per gram of liver. The density distribution of HCV in iodixanol gradients showed a peak at 1(.)04 g ml(-1) with 73 % of virus below 1(.)08 g ml(-1). Full-length HCV RNA was detected by Northern blotting and the ratio between positive- and negative-strand HCV RNA was determined as 60. HCV was partially purified by precipitation with heparin/Mn2+ and a single species of each of the three structural proteins, core, E1 and E2, was detected by Western blotting. The molecular mass of core was 20 kDa, which corresponds to the mature form from recombinant sources. The molecular mass of glycoprotein El was 31 kDa before and 21 kDa after deglycosylation with PNGase F or endoglycosidase H. Glycoprotein E2 was 62 kDa before and 36 kDa after deglycosylation, but E2-P7 was not detected. This was in contrast to recombinant sources of E2 which contain E2-P7.
引用
收藏
页码:1497 / 1507
页数:11
相关论文
共 58 条
[1]   Characterization of low- and very-low-density hepatitis C virus RNA-containing particles [J].
André, P ;
Komurian-Pradel, F ;
Deforges, S ;
Perret, M ;
Berland, JL ;
Sodoyer, M ;
Pol, S ;
Bréchot, C ;
Paranhos-Baccalà, G ;
Lotteau, V .
JOURNAL OF VIROLOGY, 2002, 76 (14) :6919-6928
[2]  
[Anonymous], 2001, FIELDS VIROLOGY
[3]  
[Anonymous], WKLY EPIDEMIOL REC
[4]   Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen [J].
Aoyagi, K ;
Ohue, C ;
Iida, K ;
Kimura, T ;
Tanaka, E ;
Kiyosawa, K ;
Yagi, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (06) :1802-1808
[5]   Replication of hepatitis C virus [J].
Bartenschlager, R ;
Lohmann, V .
JOURNAL OF GENERAL VIROLOGY, 2000, 81 :1631-1648
[6]   Long-term outcome of chronic hepatitis C virus infection in primary hypogammaglobulinaemia [J].
Bjoro, K ;
Skaug, K ;
Haaland, T ;
Froland, SS .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 1999, 92 (08) :433-441
[7]   Massive data discrimination via linear support vector machines [J].
Bradley, PS ;
Mangasarian, OL .
OPTIMIZATION METHODS & SOFTWARE, 2000, 13 (01) :1-10
[8]  
BURSTEIN M, 1970, J LIPID RES, V11, P583
[9]   ISOLATION OF A CDNA CLONE DERIVED FROM A BLOOD-BORNE NON-A, NON-B VIRAL-HEPATITIS GENOME [J].
CHOO, QL ;
KUO, G ;
WEINER, AJ ;
OVERBY, LR ;
BRADLEY, DW ;
HOUGHTON, M .
SCIENCE, 1989, 244 (4902) :359-362
[10]   GENETIC ORGANIZATION AND DIVERSITY OF THE HEPATITIS-C VIRUS [J].
CHOO, QL ;
RICHMAN, KH ;
HAN, JH ;
BERGER, K ;
LEE, C ;
DONG, C ;
GALLEGOS, C ;
COIT, D ;
MEDINASELBY, A ;
BARR, PJ ;
WEINER, AJ ;
BRADLEY, DW ;
KUO, G ;
HOUGHTON, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (06) :2451-2455